Treatment of Active Pemphigoid Gestationis in the Post-Partum or Post-Abortion Period

This protocol covers pemphigoid gestationis that remains active following delivery or pregnancy loss — a presentation that occurs outside of pregnancy itself, in the post-partum or post-abortion period, and that calls for a specific therapeutic strategy distinct from in-pregnancy management.

First-line management in this period centres on immunosuppressant or immunomodulating therapy. One agent used in this setting requires specific infant monitoring when the mother is breastfeeding.

The complete structured regimen — agent selection, sequencing, clinical considerations, and full evidence base — is available in the full protocol below.